Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
ABBV LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving AbbVie Inc Pharmaceutical Investing
CLASS ACTION UPDATE for SDIG, AUPH and RSKD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
AbbVie to Showcase Oncology Portfolio and Pipeline During the 2022 ASCO and EHA Annual Congresses Pharmaceutical Investing
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress Life Science Investing
AbbVie Awards 45 Scholarships to U.S. Students Living with Chronic, Immune-Mediated Diseases in Their Pursuit of Higher Education Pharmaceutical Investing
Albert Labs' Pre-Clinical Analytical and Toxicological Research Supports Company's Forthcoming Studies Pharmaceutical Investing
Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi® Pharmaceutical Investing
New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis Pharmaceutical Investing
Knight to Present at the 2022 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
